Dataset Information


ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.

ABSTRACT: Iron-mediated generation of highly toxic Reactive Oxygen Species (ROS) plays a major role in the process leading to iron overload-related diseases. The long-term subcutaneous administration of Deferoxamine (DFO) is currently clinically-approved to improve patient symptoms and survival. However, non-specific toxicity and short circulation times of the drug in humans often leads to poor patient compliance. Herein, thioketal-based ROS-responsive polymeric nanogels containing DFO moieties (rNG-DFO) were designed to chelate iron and to degrade under oxidative stimuli into fragments <10?nm to enhance excretion of iron-bound chelates. Serum ferritin levels and iron concentrations in major organs of IO mice decreased following treatment with rNG-DFO, and fecal elimination of iron-bound chelates increased compared to free DFO. Furthermore, rNG-DFO decreased iron mediated oxidative stress levels in vitro and reduced iron-mediated inflammation in the liver of IO mice. The study confirms that ROS-responsive nanogels may serve as a promising alternative to DFO for safer and more efficient iron chelation therapy.


PROVIDER: S-EPMC6035766 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4751432 | BioStudies
2018-01-01 | S-EPMC5845769 | BioStudies
2020-01-01 | S-EPMC7492296 | BioStudies
2015-01-01 | S-EPMC4434227 | BioStudies
2015-01-01 | S-EPMC4545510 | BioStudies
2020-01-01 | S-EPMC7648692 | BioStudies
2017-01-01 | S-EPMC5334144 | BioStudies
2019-01-01 | S-EPMC6456044 | BioStudies
1000-01-01 | S-EPMC4775857 | BioStudies
1000-01-01 | S-EPMC5938711 | BioStudies